Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_assertion type Assertion NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_head.
- NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_assertion wasGeneratedBy ECO_0000203 NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_provenance.
- NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_assertion wasDerivedFrom befree-20140225 NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_provenance.
- NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_assertion SIO_000772 18395081 NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_provenance.
- NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_assertion evidence source_evidence_literature NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_provenance.
- NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_assertion description "[Of patients with CP1 mRNA(+) tumors, more than 50% had CP1-responsive CD4(+) and CD8(+) T cells and 30% spontaneous-occurring antibodies against CP1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530171.RAbjidS6ekViQHdrNLGyBlGAvgZOA0OW-O2hxeGVcX4eQ130_provenance.